ArticleThe Journal of antimicrobial chemotherapy2023

Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.

Lucia Graziani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.